Fridley, Brooke L

Positions

• , Peter MacCallum Cancer Centre
• , Roswell Park Cancer Institute
• , University of Kansas
• , University of Kansas Medical Center
• , Moffitt Cancer Center
• , University of Kansas Cancer Center
• , Mayo Clinic
• , German Cancer Research Center
• , Authors' Affiliations: Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Texas, School of Public Health, Houston, Texas; Queensland Institute of Medical Research, Brisbane, Australia; Peter MacCallum Cancer Centre, East Melbourne, Australia; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii; Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;Gynecologic Clinic, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Departments of Health Sciences Research and Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Community and Family Medicine, Obstetrics and Gynecology, and Statistical Science, Duke University; Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina; Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, California; Gynaecological Center Research Centre, Women's Cancer, Institute for Women's Health, University College London;Sections of Epidemiology and Genetics at the Institute of Cancer Research and Breakthrough Breast Cancer Research Centre, London, United Kingdom; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland; Departments of Gynecology, Epidemiology, Biostatistics and HTA, and Urology, Radboud University Medical Centre, Nijmegen; Comprehensive Cancer Center the Netherlands, Utrecht, the Netherlands; Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California; Cancer Research UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Epidemiology and Public Health, Yale University School of Public Health, New Haven, Connecticut; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts; Department of Community and Family Medicine, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; and Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas
• , Honglin Song, Ed Dicks, Jonathan P. Tyrer, Patricia Harrington, Jennifer Alsop, and Paul D.P. Pharoah, University of Cambridge; Mercedes Jimenez-Linan, Addenbrooke's Hospital, Cambridge; Jane Hayward, Lindsay Fraser, Susan Philpott, Christopher Anderson, Adam Rosenthal, Aleksandra Gentry-Maharaj, Usha Menon, and Ian J. Jacobs, University College London; David D. Bowtell, Imperial College London, London; Ian J. Jacobs, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom; Susan J. Ramus, Maria P. Intermaggio, Christopher K. Edlund, David Conti, and Simon A. Gayther, University of Southern California, Los Angeles, CA; David D. Bowtell and Kathryn Alsop, Peter MacCallum Cancer Centre, East Melbourne; David D. Bowtell, University of Melbourne, Melbourne, Victoria, Australia; Mine S. Cicek, Julie M. Cunningham, and Ellen L. Goode, Mayo Clinic, Rochester, MN; Brooke L. Fridley, University of Kansas Medical Center, Kansas City, KS; Estrid Høgdall, Allan Jensen, and Susanne Krüger, Danish Cancer Society Research Center; Estrid Høgdall, Herlev Hospital, University of Copenhagen; Claus K. Høgdall and Susanne Krüger, Rigshospitalet, Copenhagen, Denmark; Jan Lubiński, Tomasz Huzarski, Anna Jakubowska, and Jacek Gronwald, Pomeranian Medical University, Szczecin, Poland; and Samantha Poblete, Shashi Lele, Lara Sucheston-Campbell, Kirsten B. Moysich, and Kunle Odunsi, Roswell Park Cancer Institute, Buffalo, NY.
• , University of Kansas Medical Center Kansas City KS